⌘K

Home/Filings/4/0001209191-22-029091

4//SEC Filing

Booth Andrew 4

Accession 0001209191-22-029091

CIK 0001703057other

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 2:13 PM ET

Size

5.2 KB

Accession

0001209191-22-029091

Insider Transaction Report

Form 4

Period: 2022-05-12

AbCellera Biologics Inc.ABCL

Chief Financial Officer

Transactions

Purchase
Common Shares
2022-05-12$5.79/sh+85,000$492,150→ 138,500 total

Holdings

Common Shares
(indirect: By Spouse)
130,959

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1

filerCIK 0001834411

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 2:13 PM ET
Size: 5.2 KB

View on SEC.gov